Coexistence of Kaposi’s sarcoma and psoriasis: is there a hidden relationship?
The relationship between Kaposi’s sarcoma (KS) and psoriasis is still controversial.
To analyse the association between KS and psoriasis, address the hypothesis of a reciprocal influence between the two conditions relative to clinical presentation and evolution, and consider the best therapeutic approach to be used for the treatment of psoriasis in KS patients in order to avoid the typical induction or worsening of KS during immunosuppression.
Materials & Methods
We retrospectively reviewed clinical records of 37 patients with KS and psoriasis. Fisher’s exact test was performed in order to compare epidemiological and clinical data between subsets of patients.
The prevalence of psoriasis in our KS population (n = 1407) was 2.6%. There were no statistically significant differences in terms of stage or rate of progression between KS patients with and without psoriasis, except for a higher frequency of patients with KS Stage IIB among patients with KS and psoriasis (p = 0.001).
Patients with psoriasis have a risk of KS comparable to that of the general population. Psoriasis and KS do not appear to influence each other. For the treatment of psoriasis in KS patients, one should take into account the KS-inducing potential of certain anti-psoriatic drugs.
Key wordsKaposi’s sarcoma psoriasis psoriatic arthritis
Unable to display preview. Download preview PDF.
- 5.Tebbe B, Mayer–da–Silva A, Garbe C, von Keyserlingk HJ, Orfanos CE. Genetically determined coincidence of Kaposi sarcoma and psoriasis in an HIV–negative patient after prednisolone treatment. Spontaneous regression 8 months after discontinuing therapy. Int J Dermatol 1991; 30: 114–20.PubMedGoogle Scholar
- 8.Fargnoli MC, Peris K, Frascione P, et al. Psoriasis. Kaposi’s sarcoma and Hodgkin’s disease in a patient with Down’s syndrome. Dermatology 2004; 209: 158–9.Google Scholar
- 16.Florek AG, Eilers D, Armstrong AW. A case of Kaposi sarcoma in an immunocompetent, heterosexual Irish man:a discussion of etiology and viral transmission. Dermatol Online J 2015; 21: 10.Google Scholar
- 29.Tan Y, Wang Y, Li L, Xia J, Peng S, He Y. Chemokinelike factor 1–derived C–terminal peptides induce the proliferation of dermal microvascular endothelial cells in psoriasis. PLoS One 2015; 10:e0125073.Google Scholar
- 30.Samaniego F, Markham PD, Gendelman R, et al. Vascular endothelial growth factor and basic fibroblast growth factor present in Kaposi’s sarcoma (KS) are induced by inflammatory cytokines and synergize to promote vascular permeability and KS lesion development. Am J Pathol 1998; 152: 1433–43.PubMedPubMedCentralGoogle Scholar
- 37.Wall D, McMenamin M, O’Mahony D, Irvine AD. Kaposi sarcoma in a patient with atopic dermatitis treated with ciclosporin. BMJ Case Rep 2013;2013.Google Scholar